NDC 17478-609-01 - ZIOPTAN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17478-609
- Requested NDC
- 17478-609-01
- Package NDCs from labels
- 17478-609-01, 17478-609-90, 17478-609-30, 17478-609-10
- Manufacturer
- Akorn
- Effective date
- 2022-10-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ZIOPTAN - Akorn | Akorn | 2022-10-04 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17478-609-01 | ZIOPTAN | 10 in 1 POUCH | SOLUTION/ DROPS | 10 | 10 | |
| 17478-609-01 | ZIOPTAN | 0.3 mL in 1 VIAL, SINGLE-USE | SOLUTION/ DROPS | 0.3 | 10 | |
| 17478-609-10 | ZIOPTAN | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | 10 | |
| 17478-609-30 | ZIOPTAN | 3 in 1 CARTON | SOLUTION/ DROPS | 3 | 10 | |
| 17478-609-90 | ZIOPTAN | 9 in 1 CARTON | SOLUTION/ DROPS | 9 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17478-609-01 | EA - Each | 17478-609 | 08d454dd-4bac-4f88-ae52-b1535c54ce1f | 1 | 2015-07-20 |
| 17478-609-30 | EA - Each | 17478-609 | 90cf9725-5826-47c8-91f9-0d75126df853 | 1 | 2015-01-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Tafluprost | ACTIVE INGREDIENT | 1O6WQ6T7G3 | ZIOPTAN (TAFLUPROST) SOLUTION/ DROPS [AKORN, INC.] | 2 | |
| Tafluprost | ACTIVE MOIETY | 1O6WQ6T7G3 | ZIOPTAN (TAFLUPROST) SOLUTION/ DROPS [AKORN, INC.] | 2 | |
| Edetate Disodium | INACTIVE INGREDIENT | 7FLD91C86K | ZIOPTAN (TAFLUPROST) SOLUTION/ DROPS [AKORN, INC.] | 2 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | ZIOPTAN (TAFLUPROST) SOLUTION/ DROPS [AKORN, INC.] | 2 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | ZIOPTAN (TAFLUPROST) SOLUTION/ DROPS [AKORN, INC.] | 2 | |
| Polysorbate 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | ZIOPTAN (TAFLUPROST) SOLUTION/ DROPS [AKORN, INC.] | 2 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | ZIOPTAN (TAFLUPROST) SOLUTION/ DROPS [AKORN, INC.] | 2 | |
| Sodium Phosphate, Monobasic, Dihydrate | INACTIVE INGREDIENT | 5QWK665956 | ZIOPTAN (TAFLUPROST) SOLUTION/ DROPS [AKORN, INC.] | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | ZIOPTAN (TAFLUPROST) SOLUTION/ DROPS [AKORN, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lights Lemon Glycerin | GLYCERIN | Lights Medical Manufacture Co., Ltd. | c38638af-f367-4780-8295-022d959e79ca | 2026-11-09 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-11-04 | Warnings | PDC6A3C0OX |
| Lemon Glycerine Swabsticks | GLYCERINE | PHOENIX HEALTHCARE SOLUTIONS, LLC | 436919f7-14cd-4318-9388-b3e1cbec176b | 2026-11-03 | Warnings | PDC6A3C0OX |
| hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Shield Line LLC | 5f635795-cb5b-cab4-e063-6394a90a7a9a | 2026-11-03 | Warnings | PDC6A3C0OX |
| Huddle Barrier Balm | GLYCERIN | Better Barrier Co. | 5b3cf1ed-082b-15cf-e063-6394a90a688e | 2026-11-02 | Warnings | PDC6A3C0OX |
| ENCON EYEWASH | EYEWASH | Encon Safety Products, Inc. | 485c691e-f6a8-4836-e063-6294a90a16fc | 2026-10-29 | Warnings | 059QF0KO0R |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2026-10-26 | Warnings | PDC6A3C0OX |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2026-10-26 | Warnings | PDC6A3C0OX |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2026-10-23 | Warnings | PDC6A3C0OX |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-10-21 | Warnings | 059QF0KO0R |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-10-19 | Warnings | 059QF0KO0R |
| Rohto Max Strength | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | e4b49550-1ca3-4bd7-854d-409b53fa5e26 | 2026-10-16 | Warnings | 6OZP39ZG8H |
| Clear Eyes Cooling Redness Relief | GLYCERIN AND NAPHAZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 38d14e99-e4c8-431b-b106-578eeb38bf3c | 2026-10-15 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.